Dr. Gustavo Arturo Mondragon, MD

Dr. Mondragon practices at Sharp Chula Vista Medical Center in Chula Vista, California, part of Sharp HealthCare.

Dr. Mondragon's NPI, 1619080041, was assigned on August 17, 2006. Dr. Mondragon graduated from Universidad Nacional Autonoma de Mexico in 1971. Dr. Mondragon holds California license A40640.

Dr. Mondragon's primary practice is Sharp Chula Vista Medical Center, at 751 Medical Center Court, Chula Vista, CA 91911 in San Diego County. The practice phone is (619) 502-5800.

Dr. Mondragon's primary practice is Sharp Chula Vista Medical Center in Chula Vista, California, part of Sharp HealthCare. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Mondragon to 5 more home health agencies, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mondragon practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Mondragon's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Mondragon's licenses on file in 2 states: California and Illinois.

Dmand AI lists atrial fibrillation and flutter, cardiac arrhythmia, cardiomyopathy, cerebrovascular disease, chest pain, chronic hypertension, chronic skin ulcer and congestive heart failure among the conditions Dr. Mondragon treats.

CMS data shows 1,029 Medicare services from Dr. Mondragon across 9 procedure codes in 2024, for 148 Medicare patients. Medicare paid $75,725 for them. Every service was in an office.

CMS counts 148 Medicare patients who saw Dr. Mondragon in 2024. The largest group is 75 to 84, with 64 patients. 75% of them have diabetes, and 75% have high blood pressure. 72% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mondragon's median patient age at 72, with 53% women.

In 2024, Dr. Mondragon wrote 12,139 Medicare Part D claims for 680 patients. 82% of them were for generic drugs. CMS names the drug for 11,328 of them, across 148 drugs with 11 or more claims each, at $1,825,811 in total drug cost. In 2023, CMS named 10,453 claims across 142 drugs.

Dr. Mondragon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 678 general payments to Dr. Mondragon from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 83% of the total. Medtronic Vascular, Inc. paid the most, $4,296.

Dr. Mondragon graduated from Universidad Nacional Autonoma de Mexico in 1971. Dr. Mondragon is a member of ACC.

Dr. Mondragon is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.